Upadacitinib treatment in pediatric Crohn's disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN.

Spencer EA, Cohen S, Dubinsky MC, Suskind DL, Mitrova K, Hradsky O, Conrad MA, Kelsen JR, Sladek M, Yeh PJ, Tzivinikos C, Henderson P, Wlazlo M, Hackl L, Shouval DS, Mouratidou N, Bramuzzo M, Urlep D, Olbjørn C, D'Orsi M, Schneider AM, Pujol-Muncunill G, Gotesdyner L, Kang B, Gasparetto M, Rungø C, Romano C, Miele E, Kolho KL, Hojsak I, Norsa L, Rinawi F, Sansotta N, Magen Rimon R, Granot M, Scarallo L, Trindade E, Velasco Rodríguez-Belvís M, Turner D, Yerushalmy-Feler A.

Open source

DOI
10.1093/ecco-jcc/jjag125
Published
2026-09-01
Container
J Crohns Colitis
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ecco-jcc/jjag125,
  title = {Upadacitinib treatment in pediatric Crohn's disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN.},
  author = {Spencer EA and  Cohen S and  Dubinsky MC and  Suskind DL and  Mitrova K and  Hradsky O and  Conrad MA and  Kelsen JR and  Sladek M and  Yeh PJ and  Tzivinikos C and  Henderson P and  Wlazlo M and  Hackl L and  Shouval DS and  Mouratidou N and  Bramuzzo M and  Urlep D and  Olbjørn C and  D'Orsi M and  Schneider AM and  Pujol-Muncunill G and  Gotesdyner L and  Kang B and  Gasparetto M and  Rungø C and  Romano C and  Miele E and  Kolho KL and  Hojsak I and  Norsa L and  Rinawi F and  Sansotta N and  Magen Rimon R and  Granot M and  Scarallo L and  Trindade E and  Velasco Rodríguez-Belvís M and  Turner D and  Yerushalmy-Feler A.},
  year = {2026},
  journal = {J Crohns Colitis},
  doi = {10.1093/ecco-jcc/jjag125},
  url = {https://doi.org/10.1093/ecco-jcc/jjag125}
}

RIS

TY  - JOUR
TI  - Upadacitinib treatment in pediatric Crohn's disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN.
AU  - Spencer EA
AU  -  Cohen S
AU  -  Dubinsky MC
AU  -  Suskind DL
AU  -  Mitrova K
AU  -  Hradsky O
AU  -  Conrad MA
AU  -  Kelsen JR
AU  -  Sladek M
AU  -  Yeh PJ
AU  -  Tzivinikos C
AU  -  Henderson P
AU  -  Wlazlo M
AU  -  Hackl L
AU  -  Shouval DS
AU  -  Mouratidou N
AU  -  Bramuzzo M
AU  -  Urlep D
AU  -  Olbjørn C
AU  -  D'Orsi M
AU  -  Schneider AM
AU  -  Pujol-Muncunill G
AU  -  Gotesdyner L
AU  -  Kang B
AU  -  Gasparetto M
AU  -  Rungø C
AU  -  Romano C
AU  -  Miele E
AU  -  Kolho KL
AU  -  Hojsak I
AU  -  Norsa L
AU  -  Rinawi F
AU  -  Sansotta N
AU  -  Magen Rimon R
AU  -  Granot M
AU  -  Scarallo L
AU  -  Trindade E
AU  -  Velasco Rodríguez-Belvís M
AU  -  Turner D
AU  -  Yerushalmy-Feler A.
PY  - 2026
JO  - J Crohns Colitis
DO  - 10.1093/ecco-jcc/jjag125
UR  - https://doi.org/10.1093/ecco-jcc/jjag125
ER  -

APA

EA, S., S, C., MC, D., DL, S., K, M., O, H., MA, C., JR, K., M, S., PJ, Y., C, T., P, H., M, W., L, H., DS, S., N, M., M, B., D, U., C, O., M, D., AM, S., G, P., L, G., B, K., M, G., C, R., C, R., E, M., KL, K., I, H., L, N., F, R., N, S., R, M. R., M, G., L, S., E, T., M, V. R., D, T., & A., Y. (2026). Upadacitinib treatment in pediatric Crohn's disease: 52-week outcomes of an international multicenter retrospective cohort study from the pediatric IBD Porto Group of ESPGHAN.. J Crohns Colitis. https://doi.org/10.1093/ecco-jcc/jjag125

Source records